Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans

ASAIO Journal

Volumn 49, Issue 4, 2003, Pages 430-434

  Nakamura, Tsukasa ^a   Matsuda, Takaharu ^a   Suzuki, Yukiko ^a   Ueda, Yoshihiko ^b   Koide, Hikaru ^c  

^a Misato Junshin Hospital   (Japan)

^b DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KOTO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS; PATIENT TREATMENT; TISSUE;

PLASMA MATRIX;

PROTEINS;

BICARBONATE; GELATINASE B; LOW DENSITY LIPOPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; APHERESIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIALYSATE; ENZYME BLOOD LEVEL; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; UPREGULATION;

ARTERIOSCLEROSIS OBLITERANS; BLOOD COMPONENT REMOVAL; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS, LDL; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; RENAL DIALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0041807743     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Moriarty PM, Gibson CA: Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses. Curr Atheroscler Rep 3: 156-162, 2001.
2. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM: Identification of 92 KD gelatinase in human coronary atherosclerotic lesions: Association of active enzyme synthesis with unstable angina. Circulation 91: 2125-2131, 1995.
3. Sorbi D, French DL, Nuovo GJ, Kew RR, Arbeit LA, Gruber BL: Elevated levels of 92-Kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis. Arthritis Rheum 39: 1747-1753, 1996.
4. Ebihara I, Nakamura T, Tomino Y, Shimada N, Koide H: Metalloproteinase-9 mRNA expression in monocytes from patients with chronic renal failure. Am J Nephrol 18: 305-310, 1998.
5. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503, 1994.
6. Knox JB, Sukhova GK, Whittemore AD: Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95: 205-212, 1997.
7. Nakamura M, Tachieda R, Niinuma H, et al: Circulating biochemical marker levels of collagen metabolism are abnormal in patients with abdominal aortic aneurysm. Angiology 51: 385-392, 2000.
8. Kizaki Y, Ueki Y, Yoshida K, et al: Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease? Blood Coagul Fibrinolysis 10: 341-349, 1999.
9. Harvey KB, Blumankranz MJ, Levine SE, Blackburn GL: Nutritional assessment and treatment in chronic renal failure. Am J Clin Nutr 33: 1586-1597, 1980.
10. Nakamura T, Ushiyama C, Shoji H, Koide H: Effects of hemoperfusion on serum cardiac troponin T concentrations using polymyxin B-immobilized fibers in septic patients undergoing hemodialysis. ASAIO J 48: 41-44, 2002.
11. Nakamura T, Ushiyama C, Suzuki Y, Shoji H, Shimada N, Koide H: Hemoperfusion with polymyxin B-immobilized fibers for urinary albumin excretion in septic patients with trauma. ASAIO J 48: 244-248, 2002.
12. Friedewald WT, Levy RI, Friedrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 18: 499-504, 1972.
13. Fujimoto N, Hosokawa N, Iwata K, Shinza T, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase-9 (92 kD gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin Chim Acta 231: 79-88, 1994.
14. Nakamura T, Ushiyama C, Suzuki S, Ebihara I, Shimada N, Koide H: Evaluation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease. Am J Nephrol 20: 32-36, 2000.
15. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T: Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol Methods 127: 103-108, 1990.
16. Nakamura T, Ushiyama C, Shimada N, et al: Changes in concentrations of type IV collagen and tissue inhibitor of metalloproteinase-1 in patients with paraquat poisoning. J Appl Toxicol 21: 445-447, 2001.
17. US Renal Data System (USRDS): USRDS 1997 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, 1997.
18. Koga N: Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleroderma in patients with severe hypercholesterolemia. Ther Apher 5: 244-251, 2001.
19. Agishi T, Nakasato S, Ota K: Prognosis of patients with arteriosclerosis obliterans treated with LDL-apheresis. Vasc Surg 28: 513-517, 1994.
20. Ye S, Humphries S, Henney A: Matrix metalloproteinases: Implication in vascular matrix remodeling during atherogenesis. Clin Sci 94: 103-110, 1998.
21. Hojo Y, Ikeda U, Katsuki T, Mizuno O, Fujikawa H, Shimada K: Matrix metalloproteinase expression in the coronary circulation induced by coronary angioplasty. Atherosclerosis 161: 185-192, 2002.
22. Kalela A, Koivu TA, Hoyhtya M, et al: Association of serum MMP-9 with autoantibodies against oxidized LDL. Atherosclerosis 160: 161-165, 2002.
23. Huang Y, Song L, Wu S, Fan F, Lopes-Virella MF: Oxidized LDL differentially regulates MMP-1 and TIMP-1 expression in vascular endothelial cells. Atherosclerosis 156: 119-125, 2001.
24. Kalela A, Ponnjo M, Koivu TA, et al: Association of serum sialic acid and MMP-9 with lipids and inflammatory markers. Eur J Clin Invest 30: 99-104, 2000.
25. Murphy G, Reynolds JJ, Werb Z: Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture: Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin-1 in parallel with collagenase. J Biol Chem 30: 3079-3083, 1985.
26. Mii S, Mori A, Sakata H, Nakayama M, Tsuruta H: LDL apheresis for arteriosclerosis obliterans with occluded bypass graft: Changes in prostacyclin and effect on ischemic symptoms. Angiology 49: 175-180, 1998.
27. Agishi T, Naganuma S, Nakasato S, et al: Treatment of arteriosclerotic obstruction by LDL adsorption. Angiology 44: 222-227, 1993.
28. Yoshimura Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M: Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinase-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 38: 969-975, 1995.